Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07552922 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1

Study acronym: DINGO
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 27, 2026 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This study aims to explore the perceptions of men with prostate cancer (PCa) and high-risk biochemical recurrence (BCR) regarding the risk of breast-related side effects, including gynaecomastia, from treatment.
Trial Details
NCT Number NCT07552922
Lead Sponsor St Vincent's Hospital, Sydney
Collaborators: University of Technology, Sydney
Conditions
(from sponsor)		 Prostate Cancer (Adenocarcinoma)
Related terms Adenocarcinoma, Gynecomastia, Prostatic Neoplasms
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov